Format

Send to

Choose Destination
Neuroimage Clin. 2017 Aug 26;16:539-544. doi: 10.1016/j.nicl.2017.08.021. eCollection 2017.

Improved prediction of outcome in Parkinson's disease using radiomics analysis of longitudinal DAT SPECT images.

Author information

1
Department of Radiology, Johns Hopkins University, Baltimore, United States.
2
Department of Electrical & Computer Engineering, Johns Hopkins University, Baltimore, United States.
3
Departments of Oncology and Biostatistics, Johns Hopkins University, Baltimore, United States.
4
Department of Physics & Astronomy, University of British Columbia, Vancouver, Canada.
5
Departments of Radiology and Research Administration, Henry Ford Health System, Detroit, MI, United States.
6
School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
7
Department of Neurology and Neurosurgery, Johns Hopkins University, Baltimore, MD, United States.
8
CIPCE, School of Electrical & Computer Engineering, University of Tehran, Tehran, Iran.

Abstract

No disease modifying therapies for Parkinson's disease (PD) have been found effective to date. To properly power clinical trials for discovery of such therapies, the ability to predict outcome in PD is critical, and there is a significant need for discovery of prognostic biomarkers of PD. Dopamine transporter (DAT) SPECT imaging is widely used for diagnostic purposes in PD. In the present work, we aimed to evaluate whether longitudinal DAT SPECT imaging can significantly improve prediction of outcome in PD patients. In particular, we investigated whether radiomics analysis of DAT SPECT images, in addition to use of conventional non-imaging and imaging measures, could be used to predict motor severity at year 4 in PD subjects. We selected 64 PD subjects (38 male, 26 female; age at baseline (year 0): 61.9 ± 7.3, range [46,78]) from the Parkinson's Progressive Marker Initiative (PPMI) database. Inclusion criteria included (i) having had at least 2 SPECT scans at years 0 and 1 acquired on a similar scanner, (ii) having undergone a high-resolution 3 T MRI scan, and (iii) having motor assessment (MDS-UPDRS-III) available in year 4 used as outcome measure. Image analysis included automatic region-of-interest (ROI) extraction on MRI images, registration of SPECT images onto the corresponding MRI images, and extraction of radiomic features. Non-imaging predictors included demographics, disease duration as well as motor and non-motor clinical measures in years 0 and 1. The image predictors included 92 radiomic features extracted from the caudate, putamen, and ventral striatum of DAT SPECT images at years 0 and 1 to quantify heterogeneity and texture in uptake. Random forest (RF) analysis with 5000 trees was used to combine both non-imaging and imaging variables to predict motor outcome (UPDRS-III: 27.3 ± 14.7, range [3,77]). The RF prediction was evaluated using leave-one-out cross-validation. Our results demonstrated that addition of radiomic features to conventional measures significantly improved (p < 0.001) prediction of outcome, reducing the absolute error of predicting MDS-UPDRS-III from 9.00 ± 0.88 to 4.12 ± 0.43. This shows that radiomics analysis of DAT SPECT images has a significant potential towards development of effective prognostic biomarkers in PD.

KEYWORDS:

DAT SPECT; Longitudinal; Outcome prediction; Parkinson's disease; Radiomics; Textural features

PMID:
29868437
PMCID:
PMC5984570
DOI:
10.1016/j.nicl.2017.08.021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center